As I recall, the Russian approval PR was issued very close to the time that the FDA application was submitted. I read that PR as a confirmation of the legitimacy of LTC, another regulatory body confirming the safety and validity of LTC. I certainly didn't read it as CTUM suggesting they had access to those markets.
Jumping from the fact that Lowman presented those PRs as indicative of potential revenues to calling CTUM a "smoke and mirror" company is a true "bunch of BS".
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.